Central blood pressure, arterial stiffness, and wave reflection: New targets of treatment in essential hypertension

Current Hypertension Reports

Volumn 11, Issue 3, 2009, Pages 190-196

  Ghiadoni, Lorenzo ^b   Bruno, Rosa Maria ^b   Stea, Francesco ^b   Virdis, Agostino ^b   Taddei, Stefano ^a  

^a UNIVERSITY OF PISA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INDAPAMIDE PLUS PERINDOPRIL; PERINDOPRIL; PLACEBO; TELMISARTAN; THIAZIDE DIURETIC AGENT; VASOACTIVE AGENT;

ANTIHYPERTENSIVE ACTIVITY; ARTERIAL STIFFNESS; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CLINICAL TRIAL; DRUG MECHANISM; DRUG TARGETING; ESSENTIAL HYPERTENSION; HEART HEMODYNAMICS; HEART LEFT VENTRICLE HYPERTROPHY; HEART PROTECTION; HUMAN; LONG TERM CARE; MORBIDITY; MORTALITY; PRACTICE GUIDELINE; PREDICTION; PULSE WAVE; REVIEW; RISK ASSESSMENT; TARGET ORGAN;

ANTIHYPERTENSIVE AGENTS; ARTERIES; BLOOD PRESSURE; HUMANS; HYPERTENSION; TREATMENT OUTCOME; VASOCONSTRICTION;

EID: 65749088243     PISSN: 15226417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11906-009-0034-5     Document Type: Review

References (50)

1. Mancia G, De Backer G, Dominiczak A, et al.: 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007, 25:1105-1187.
2. Lewington S, Clarke R, Qizilbash N, et al.: Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002, 360:1903-1913.
3. Turnbull F: Effects of different blood-pressure-lowering regimens on major cardiovascular events: Results of prospectively-designed overviews of randomised trials. Lancet 2003, 362:1527-1535.
4. Staessen JA, Li Y, Thijs L, Wang JG: Blood pressure reduction and cardiovascular prevention: An update including the 2003-2004 secondary prevention trials. Hypertens Res 2005, 28:385-407.
5. Salvetti A, Ghiadoni L: Guidelines foA antihypertensive treatment: an update after the ALLHAT study. J Am Soc Nephrol 2004, 15: S51-S54.
6. Laurent S, Cockcroft J, Van Bortel L, et al.: Expert consensus document on arterial stiffness: Methodological issues and clinical applications. Eur Heart J 2006, 27:2588-2605.
7. Nichols WW, O'Rourke MF: McDonald's Blood Flow in Arteries: Theoretical, Experimental and Clinical Principles, edn 5. New York: Oxford University Press; 2005:624.
8. Oparil S, Izzo JL Cr: Pulsology rediscovered: commentary on the Conduit Artery Function Evaluation (CAFE) study. Circulation 2006, 113:1162-1163.
9. Dahlof B, Devereux RB, Kjeldsen SE, et al.: Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol. Lancet 2002, 359:995-1003.
10. Dahlöf B, Sever PS, Poulter NR, et al.: Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): A multicentre randomised controlled trial. Lancet 2005, 366:895-906.
11. Kaplan NM, Opie LH: Controversies in hypertension. Lancet 2006, 367:168-176.
12. Giannattasio C, Failla M, Lucchina S, et al.: Arterial stiffening influence of sympathetic nerve activity: Evidence from hand transplantation in humans. Hypertension 2005, 45:608-611.
13. Giannattasio C, Failla M, Stella ML, et al.: Angiotensin-converting enzyme inhibition and radial artery compliance in patients with congestive heart failure. Hypertension 1995, 26:491-496.
14. Safar ME, Levy BI, Struijker-Boudier H: Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases. Circulation 2003, 107:2864-2869.
15. Laurent S, Boutouyrie P: Recent advances in arterial stiffness and wave reflection in human hypertension. Hypertension 2007, 49:1202-1206.
16. Izzo JL Jr: Arterial stiffness and the systolic hypertension syndrome. Curr Opin Cardiol 2004, 19:341-352.
17. O'Rourke MF, Adji A: An updated clinical primer on large artery mechanics: Implications of pulse waveform analysis and arterial tonometry. Curr Opin Cardiol 2005, 20:275-281.
18. Mitchell GF, Parise H, Benjamin EJ, et al.: Changes in arterial stiffness and wave reflection with advancing age in healthy men and women: The Framingham Heart Study. Hypertension 2004, 43:1239-1245.
19. Nichols WW, Singh BM: Augmentation index as a measure of peripheral vascular disease state. Curr Opin Cardiol 2002, 17:543-551.
20. O'Rourke MF, Staessen JA, Vlachopoulos C, et al.: Clinical applications of arterial stiffness; definitions and reference values. Am J Hypertens 2002, 15: 426-444.
21. Swillens A, Segers P: Assessment of arterial pressure wave reflection: methodological considerations. Artery Res 2008, 2:122-131.
22. Papaioannou TG, Lekakis JP, Karatzis EN, et al.: Transmission of calibration errors (input) by generalized transfer functions to the aortic pressures (output) at different hemodynamic states. Int J Cardiol 2006, 110:46-52.
23. Wilkinson IB, Mohammad NH, Tyrrell S, et al.: Heart rate dependency of pulse pressure amplification and arterial stiffness. Am J Hypertens 2002, 15:24-30.
24. McEniery CM, Yasmin, Hall IR, et al.: Normal vascular aging: differential effects on wave reflection and aortic pulse wave velocity: the Anglo-Cardiff Collaborative Trial (ACCT). J Am Coll Cardiol 2005, 46:1753-1760.
25. Shorr RI, Somes GW: Can diastolic blood pressure be excessively lowered in the treatment of isolated systolic hypertension? J Clin Hypertens (Greenwich) 2000, 2:134-137.
26. Saeki A, Recchia F, Kass DA: Systolic flow augmentation in hearts ejecting into a model of stiff aging vasculature. Influence on myocardial perfusion-demand balance. Circ Res 1995, 76:132-141.
27. Chemla D, Nitenberg A, Teboul JL, et al.: Subendocardial viability index is related to the diastolic/systolic time ratio and left ventricular filling pressure, not to aortic pressure: An invasive study in resting humans. Clin Exp Pharmacol Physiol 2008 Nov 7 (Epub ahead of print).
28. Schwartzkopff B, Motz W, Frenzel H, et al.: Structural and functional alterations of the intramyocardial coronary arterioles in patients with arterial hypertension. Circulation 1993, 88:993-1003.
29. O'Rourke MF, Safar ME: Relationship between aortic stiffening and microvascular diseasein brain and kidney: Cause and logic of therapy. Hypertension 2005, 46:200-204.
30. Laurent S, Boutouyrie P, Lacolley P: Structural and genetic bases of arterial stiffness. Hypertension 2005, 45:1050-1055.
31. Boutouyrie P, Tropeano AI, Asmar R, et al.: Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: A longitudinal study. Hypertension 2002, 39:10-15.
32. Leone N, Ducimetiere P, Gariepy J, et al.: Distension of the carotid artery and risk of coronary events: The three-city study. Arterioscler Thromb Vasc Biol 2008, 28:1392-1397.
33. Watabe D, Hashimoto J, Hatanaka R, et al.: Electrocardiographic left ventricular hypertrophy and arterial stiffness: The Ohasama study. Am J Hypertens 2006, 19:1199-1205.
34. Hermans MM, Henry R, Dekker JM, et al.: Estimated glomerular filtration rate and urinary albumin excretion are independently associated with greater arterial stiffness: The Hoorn Study. J Am Soc Nephrol 2007, 18:1942-1952.
35. London GM, Blacher J, Pannier B, et al.: Arterial wave reflections and survival in end-stage renal failure. Hypertension 2001, 38:434-438.
36. Safar ME, Blacher J, Pannier B, et al.: Central pulse pressure and mortality in end-stage renal disease. Hypertension 2002, 39:735-738.
37. Weber T, Auer J, O'Rourke MF, et al.: Increased arterial wave reflections predict severe cardiovascular events in patients undergoing percutaneous coronary interventions. Eur Heart J 2005, 26:2657-2663.
38. Williams B, Lacy PS, Thom SM, et al.: Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: Principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 2006, 113:1213-1225.
39. Chirinos JA, Zambrano JP, Chakko S, et al.: Aortic pressure augmentation predicts adverse cardiovascular events in patients with established coronary artery disease. Hypertension 2005, 45:980-985.
40. Roman MJ, Devereux RB, Kizer JR, et al.: Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: The Strong Heart Study. Hypertension 2007, 50:197-203.
41. Pini R, Cavallini MC, Palmieri V, et al.: Central but not brachial blood pressure predicts cardiovascular events in an unselected geriatric population: The ICARe Dicomano Study. J Am Coll Cardiol 2008, 51:2432-2439.
42. Dart AM, Gatzka CD, Kingwell BA, et al.: Brachial blood pressure but not carotid arterial waveforms predict cardiovascular events in elderly female hypertensives. Hypertension 2006, 47:785-790.
43. Guerin AP, Blacher J, Pannier B, et al.: Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation 2001, 103:987-992.
44. Mahmud A: Reducing arterial stiffness and wave reflection-quest for the Holy Grail? Artery Res 2007, 1:13-19.
45. Agabiti-Rosei E, Mancia G, O'Rourke MF, et al.: Central blood pressure measurements and antihypertensive therapy: A consensus document. Hypertension 2007, 50: 154-160.
46. Tropeano AI, Boutouyrie P, Pannier B, et al.: Brachial pressure-independent reduction in carotid stiffness after long-term angiotensin-converting enzyme inhibition in diabetic hypertensives. Hypertension 2006, 48:80-86.
47. Asmar RG, London GM, O'Rourke ME, Safar ME: Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patient: A comparison with atenolol. Hypertension 2001, 38:922-926.
48. de Luca N, Asmar RG, London GM, et al.: Selective reduction of cardiac mass and central blood pressure on low-dose combination perindopril/ indapamide in hypertensive subjects. J Hypertens 2004, 22:1623-1630.
49. Dart AM, Cameron JD, Gatzka CD, et al.: Similar effects of treatment on central and brachial blood pressures in older hypertensive subjects in the Second Australian National Blood Pressure Trial. Hypertension 2007, 49:1242-1247.
50. Topouchian J, El Feghali R, Pannier B, et al.: Arterial stiffness and pharmacological interventions-the TRanscend arterial stiffNess Substudy (TRANS study). Vasc Health Risk Manag 2007, 3: 381-387.